FOS and Alzheimer disease: Consistent with these findings, the ability of Ad-vaspin infection to upregulate catabolic factor expression in chondrocytes was reduced by the AP-1 inhibitor T5224 in a dose-dependent manner (Fig. 3g and Supplementary Fig. 2).